Related Experiment Video

Updated: Jul 15, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer

Ken Kawamoto1, Steven T Okino, Robert F Place

  • 1Department of Urology, Veterans Affairs Medical Center and University of California School of Medicine, San Francisco, California 94121, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|May 3, 2007
PubMed
Abstract

Insights

Epigenetic changes like DNA methylation and histone modifications silence the RASSF1A gene in prostate cancer. Restoring these modifications reactivates the gene, offering potential therapeutic targets for prostate cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Epigenetics
  • Prostate Cancer Research

Background:

  • The RAS-association domain family 1, isoform A (RASSF1A) gene is frequently inactivated in prostate cancers.
  • The precise molecular mechanisms driving RASSF1A gene silencing remain incompletely understood.

Purpose of the Study:

  • Investigate the mechanisms of RASSF1A gene inactivation in prostate cancer.
  • Analyze CpG methylation patterns and histone modifications (acetylation and H3 methylation) at the RASSF1A promoter region.

Main Methods:

  • Analyzed RASSF1A methylation in 131 prostate cancer and 65 benign prostate hypertrophy (BPH) samples using methylation-specific PCR.
  • Utilized chromatin immunoprecipitation (ChIP) assays to assess histone acetylation (acetyl-H3, acetyl-H4) and H3 methylation (dimethyl-H3-K4, dimethyl-H3-K9) at the RASSF1A promoter.

Main Results:

  • Aberrant RASSF1A methylation occurred in 74% of prostate cancers and 18.5% of BPH samples, correlating with higher Gleason sum and stage.
  • Unmethylated RASSF1A promoters showed increased histone acetylation and dimethyl-H3-K4.
  • 5-aza-2'-deoxy-cytidine treatment reversed hypermethylation, increasing acetyl-H3, acetyl-H4, and dimethyl-H3-K4, while decreasing H3K9me2.

Conclusions:

  • Reduced histone acetylation and H3K4me2 methylation, alongside increased H3K9me2 methylation, are critical for maintaining RASSF1A gene silencing in prostate cancer.
  • These epigenetic alterations are linked to promoter DNA methylation.
  • Findings suggest potential therapeutic strategies targeting epigenetic modifications for RASSF1A reactivation in prostate cancer.

More Related Videos

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...